Literature DB >> 28630941

Furthering the Continental Drift Speciation Hypothesis in the Pathogenic Cryptococcus Species Complexes.

David M Engelthaler1, Wieland Meyer2.   

Abstract

Entities:  

Keywords:  C. gattii; Cryptococcus; Pangea; speciation

Year:  2017        PMID: 28630941      PMCID: PMC5471350          DOI: 10.1128/mSphere.00241-17

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


× No keyword cloud information.

LETTER

We read with interest the continental drift hypothesis by Casadevall et al. (1) as a possible speciation driver within the Cryptococcus species complexes, adding greatly to the ongoing discussion of speciation between these complexes (2, 3). We further propose that this mechanism may also have had speciation effects within these complexes, most notably within Cryptococcus gattii, where at least four major molecular types/species are recognized (VGI, VGII, VGIII, and VGIV). It is likely that with hundreds of thousands of single nucleotide polymorphism (SNP) mutations separating the major C. gattii molecular types (4), their temporal separation is in the tens of millions of years (5, 6). C. gattii was originally considered a tropical pathogen, being endemic to Australia, Asia, Africa, and South America, with random cases appearing in North America and Europe (7, 8); it is either nonendemic or newly endemic to these latter continents due to global movement of C. gattii microhabitats, such as eucalypts (e.g., Eucalyptus camaldulensis) and Douglas fir (Pseudotsuga menziesii) (9, 10). Based on global genotype data, we noted that the molecular types appear to have hemispheric and continental associations (Fig. 1). Asian C. gattii isolates are predominantly VGI, with a low-level VGII presence in most Asian countries (11). VGIV has only been reported in India (12), and VGIII appears to be absent in Asia, except in Thailand (13). Conversely, VGIV is the dominant C. gattii molecular type in Africa (11). Only VGI and VGII have been identified in Australia, one of the first places where C. gattii was found in the environment and therefore previously considered to be a possible birthplace of C. gattii (14, 15). There are limited to no reported findings of VGIII in Australia or Africa. In Europe, except for Spain, where a significant number of VGI strains have been identified, isolates are largely clinical or associated with nonnative trees (9, 11). Most United States cases are traveler associated or are due to recent translocations of the fungus from regions of endemicity. Beyond the emergence of VGII out of Brazil into the Pacific Northwest (4, 16, 17), VGIII emergent events have occurred in California (18) and the southeastern United States (19), and VGIII also dominates among isolates from Mexico (20, 21). South America has a high degree of disease, primarily in three countries: Brazil and Columbia have predominantly VGII (22), with lower levels of VGI and VGIII (17) and, rarely, VGIV, whereas isolates in Argentina are primarily VGI (11). Numerous isolations from native Amazonian rain forest trees far removed from human interactions suggest an ancestral location for C. gattii (23–25).
FIG 1 

A Pangea representation of present day geographically dominant C. gattii populations. Note that nonendemic isolations and more recent emerged populations are not displayed. (Image adapted from https://commons.wikimedia.org/wiki/File:Pangaea_continents.png.)

A Pangea representation of present day geographically dominant C. gattii populations. Note that nonendemic isolations and more recent emerged populations are not displayed. (Image adapted from https://commons.wikimedia.org/wiki/File:Pangaea_continents.png.) Of interest are possible remnant populations from prior contiguous Pangea regions. For example, India was a contiguous landmass with southern Africa (R. W. Schlische; http://www.rci.rutgers.edu/~schlisch/103web/Pangeabreakup/breakupframe.html). It is possible that a common ancestor to VGIV was endemic to such a region prior to the break off of the Indian Subcontinent. Other interesting phylogeographic features include African VGII being found only in Senegal, a previous land partner with Brazil (17), and the presence of apparently endemic European C. gattii primarily only on the Iberian Peninsula, Europe’s Pangea connection to Africa (R. A. Krulwich; http://www.npr.org/blogs/krulwich/2013/09/12/221874851/a-most-delightful-map. This is not to suggest that the above endemic foci are all due to separation of contiguous endemic populations during the breakup of Pangea, nor does this represent an exhaustive listing of all isolations of C. gattii around the world. It is however an additional viewpoint in favor of the continental drift dispersal hypothesis.
  24 in total

1.  Natural habitat of Cryptococcus neoformans var. gattii.

Authors:  D H Ellis; T J Pfeiffer
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

2.  Genotyping of Mexican Cryptococcus neoformans and C. gattii isolates by PCR-fingerprinting.

Authors:  L R Castañón Olivares; K Martínez Martínez; R M Bermúdez Cruz; M A Martínez Rivera; W Meyer; R A Arreguín Espinosa; R López Martínez; G M Ruiz Palacios y Santos
Journal:  Med Mycol       Date:  2009-11       Impact factor: 4.076

3.  First environmental isolation of Cryptococcus gattii serotype B, from Cúcuta, Colombia.

Authors:  Carolina Firacative; Germán Torres; María Claudia Rodríguez; Patricia Escandón
Journal:  Biomedica       Date:  2011-03       Impact factor: 0.935

4.  Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia.

Authors:  Patricia Escandón; Adriana Sánchez; Marcela Martínez; Wieland Meyer; Elizabeth Castañeda
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

5.  A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada).

Authors:  S E Kidd; F Hagen; R L Tscharke; M Huynh; K H Bartlett; M Fyfe; L Macdougall; T Boekhout; K J Kwon-Chung; W Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

6.  Cryptococcus gattii, no longer an accidental pathogen?

Authors:  Deborah J Springer; Sujal Phadke; Blake Billmyre; Joseph Heitman
Journal:  Curr Fungal Infect Rep       Date:  2012-12

7.  Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States.

Authors:  Edmond J Byrnes; Wenjun Li; Yonathan Lewit; Hansong Ma; Kerstin Voelz; Ping Ren; Dee A Carter; Vishnu Chaturvedi; Robert J Bildfell; Robin C May; Joseph Heitman
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

8.  Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal.

Authors:  Deborah J Springer; R Blake Billmyre; Elan E Filler; Kerstin Voelz; Rhiannon Pursall; Piotr A Mieczkowski; Robert A Larsen; Fred S Dietrich; Robin C May; Scott G Filler; Joseph Heitman
Journal:  PLoS Pathog       Date:  2014-08-21       Impact factor: 6.823

9.  Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal.

Authors:  David M Engelthaler; Nathan D Hicks; John D Gillece; Chandler C Roe; James M Schupp; Elizabeth M Driebe; Felix Gilgado; Fabian Carriconde; Luciana Trilles; Carolina Firacative; Popchai Ngamskulrungroj; Elizabeth Castañeda; Marcia dos Santos Lazera; Marcia S C Melhem; Asa Pérez-Bercoff; Gavin Huttley; Tania C Sorrell; Kerstin Voelz; Robin C May; Matthew C Fisher; George R Thompson; Shawn R Lockhart; Paul Keim; Wieland Meyer
Journal:  mBio       Date:  2014-07-15       Impact factor: 7.867

10.  Continental Drift and Speciation of the Cryptococcus neoformans and Cryptococcus gattii Species Complexes.

Authors:  Arturo Casadevall; Joudeh B Freij; Christopher Hann-Soden; John Taylor
Journal:  mSphere       Date:  2017-04-19       Impact factor: 4.389

View more
  5 in total

1.  Molecular type distribution and fluconazole susceptibility of clinical Cryptococcus gattii isolates from South African laboratory-based surveillance, 2005-2013.

Authors:  Serisha D Naicker; Carolina Firacative; Erika van Schalkwyk; Tsidiso G Maphanga; Juan Monroy-Nieto; Jolene R Bowers; David M Engelthaler; Wieland Meyer; Nelesh P Govender
Journal:  PLoS Negl Trop Dis       Date:  2022-06-29

2.  Conservation of Intracellular Pathogenic Strategy among Distantly Related Cryptococcal Species.

Authors:  Joudeh B Freij; Man Shun Fu; Carlos M De Leon Rodriguez; Amanda Dziedzic; Anne E Jedlicka; Quigly Dragotakes; Diego C P Rossi; Eric H Jung; Carolina Coelho; Arturo Casadevall
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

3.  Corticosteroids for Posttransplant Immune Reconstitution Syndrome in Cryptococcus gattii Meningoencephalitis: Case Report and Literature Review.

Authors:  Gregory S Canfield; Andrés F Henao-Martínez; Carlos Franco-Paredes; Kristen Zhelnin; Michael L Wilson; Katherine C Shihadeh; David Wyles; Edward M Gardner
Journal:  Open Forum Infect Dis       Date:  2019-10-23       Impact factor: 3.835

Review 4.  Cryptococcus in Wildlife and Free-Living Mammals.

Authors:  Patrizia Danesi; Christian Falcaro; Laura J Schmertmann; Luisa Helena Monteiro de Miranda; Mark Krockenberger; Richard Malik
Journal:  J Fungi (Basel)       Date:  2021-01-06

Review 5.  Ecoepidemiology of Cryptococcus gattii in Developing Countries.

Authors:  Patricia F Herkert; Ferry Hagen; Rosangela L Pinheiro; Marisol D Muro; Jacques F Meis; Flávio Queiroz-Telles
Journal:  J Fungi (Basel)       Date:  2017-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.